Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Arcus Biosciences (RCUS) Leases (2020 - 2022)

Arcus Biosciences (RCUS) has 3 years of Leases data on record, last reported at $102.1 million in Q3 2022.

  • For Q3 2022, Leases rose 187.1% year-over-year to $102.1 million; the TTM value through Sep 2022 reached $102.1 million, up 187.1%, while the annual FY2021 figure was $105.0 million, 721.28% up from the prior year.
  • Leases reached $102.1 million in Q3 2022 per RCUS's latest filing, down from $104.0 million in the prior quarter.
  • Across five years, Leases topped out at $105.0 million in Q4 2021 and bottomed at $12.2 million in Q1 2021.
  • Average Leases over 3 years is $63.8 million, with a median of $69.1 million recorded in 2021.
  • The widest YoY moves for Leases: up 741.23% in 2022, down 187.1% in 2022.
  • A 3-year view of Leases shows it stood at $12.8 million in 2020, then skyrocketed by 721.28% to $105.0 million in 2021, then dropped by 2.76% to $102.1 million in 2022.
  • Per Business Quant database, its latest 3 readings for Leases were $102.1 million in Q3 2022, $104.0 million in Q2 2022, and $103.0 million in Q1 2022.